Obstetrics/Gynecology
RSSArticles
-
Clinical Briefs in Primary Care Supplement
-
Pharmacology Watch: Study Concludes Premarketing Drug Trials Underpowered
-
Medical Acupuncture — A Review
-
Full July 8, 2002, Issue in PDF
-
Full September 1, 2002 Issue in PDF
-
Reinforce instructions after Micronor alert
-
Does weight play a role in effectiveness?
-
FDA gives nod to label change for misoprostol
-
Abortion pill advisory issued
-
Role of Anti-VEGF Therapy in Platinum-resistant Recurrent Ovarian Cancer
Bevacizumab is a humanized monoclonal antibody targeting vascular endothelial growth factor and has documented single-agent activity in patients with recurrent ovarian cancer.